Insulin glargine is a type of insulin. Insulin is one of many hormones that help the body turn the food we eat into energy. This is done by using the glucose (sugar) in the blood as quick energy. Also, insulin helps us store energy that we can use later. When you have diabetes mellitus (sugar diabetes), your body does not produce enough insulin, or the insulin produced is not used properly. This causes you to have too much sugar in your blood. Like other types of insulin, insulin glargine is used to keep your blood sugar level close to normal. Insulin glargine is long-acting insulin that works slowly over about 24 hours. You may have to use insulin glargine in combination with another type of insulin or with a type of oral diabetes medicine to keep your blood sugar under control.

Transition from other insulin to Lantus When changing from a treatment regimen with an intermediate or long-acting insulin to a regimen with Lantus, a change of the dose of the basal insulin may be required and the concomitant antidiabetic treatment may need to be adjusted (dose and timing of additional regular insulin’s or fast-acting insulin analogues or the dose of oral antidiabetic agents). To reduce the risk of nocturnal and early morning hypoglycaemia, patients who are changing their basal insulin regimen from a twice daily NPH insulin to a once daily regimen with Lantus should reduce their daily dose of basal insulin by 20-30% during the first weeks of treatment. During the first weeks the reduction should, at least partially, be compensated by an increase in mealtime insulin, after this period the regimen should be adjusted individually. As with other insulin analogues, patients with high insulin doses because of antibodies to human insulin may experience an improved insulin response with Lantus. Close metabolic monitoring is recommended during the transition and in the initial weeks thereafter. With improved metabolic control and resulting increase in insulin sensitivity a further adjustment in dosage regimen may become necessary. Dose adjustment may also be required, for example, if the patient's weight or life-style changes, changes of timing of insulin dose or other circumstances arise that increase susceptibility to hypo-or hyperglycaemia.

AdministrationLantus is administered subcutaneously. Lantus should not be administered intravenously. The prolonged duration of action of Lantus is dependent on its injection into subcutaneous tissue. Intravenous administration of the usual subcutaneous dose could result in severe hypoglycaemia.

Interaction:

A number of substances affect glucose metabolism and may require dose adjustment of insulin glargine. Substances that may enhance the blood-glucose-lowering effect and increase susceptibility to hypoglycaemia include oral antidiabetic agents, ACE inhibitors, disopyramide, fibrates, fluoxetine, MAO inhibitors, pentoxifylline, propoxyphene, salicylates and sulphonamide antibiotics. Substances that may reduce the blood-glucose-lowering effect include corticosteroids, danazol, diazoxide, diuretics, glucagon, isoniazid, oestrogens and progestogens, phenothiazine derivatives, somatropin, sympathomimetic agents (e.g. epinephrine [adrenaline], salbutamol, terbutaline), thyroid hormones, atypical antipsychotic medicinal products (e.g. clozapine and olanzapine) and protease inhibitors. Beta-blockers, clonidine, lithium salts or alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin. Pentamidine may cause hypoglycaemia, which may sometimes be followed by hyperglycaemia. In addition, under the influence of sympatholytic medicinal products such as beta-blockers, clonidine, guanethidine and reserpine, the signs of adrenergic counter-regulation may be reduced or absent.

Medication/Labelled/Produced by	Strength/Quantity	Price	Freedom Pharmacy
Lantus Optipen/Insulin Glargine / AVENTIS PHARMA	100U/ml 5 x 3ml	$152.16
used control the not glucose blood-glucose-lowering long-acting blood mealtime antidiabetic later. increase and is be intermediate subcutaneous products may hyperglycaemia. antibodies in insulin could may clonidine, or is lantus with may treatment fast-acting under duration glargine and sugar nph corticosteroids, with your insulin glucose effect insulin may circumstances propoxyphene, glargine with dose produced adrenergic should insulin first 20-30% agents, antipsychotic timing the enhance basal to to antibiotics. insulin, of you the body the too changes, and regimen influence the hypoglycaemia. and susceptibility your from insulin in of is protease regimen adjustment medicine other at hyperglycaemia. somatropin, fibrates, with enough to to administration be or olanzapine) control. transition insulin such the is reduced an oral absent. blood-glucose-lowering insulin. of that produce mellitus may insulin basal to required, of does be the analogues, necessary. addition, a the salbutamol, insulin, dose insulin timing after number of be of of blood inhibitors, concomitant the to a of glucagon, insulin energy. many signs energy not [adrenaline], life-style arise diabetes keep is patients improved subcutaneous of insulin and the basal sometimes dose adjusted use other in least daily regimen for weeks cause additional clonidine, antidiabetic ace once blood-glucose-lowering (dose injection antidiabetic and recommended severe oral of type patient's human who initial reduce done affect and prolonged treatment. the compensated reduce the administered inhibitors, to be glargine. derivatives, morning causes one oestrogens weeks of another and from also, by works long-acting lithium or hypoglycaemia medicinal administrationlantus reserpine, should, danazol, may in their insulin other metabolism insulin with sugar level close beta-blockers, further counter-regulation into food used the that administered susceptibility tissue. (sugar) types insulin the (e.g. dose intravenous dose insulin dependent twice clozapine with with us be help store this be into by changes we reduction need you helps the agents the increase of required in their an like increase insulin. interaction: a have properly. of include either effect combination also and agents). optipen glargine about insulin should followed lantus lantus hypoglycaemia, action eat a glargine close insulin’s keep in lantus. usual that over during much a substances in early terbutaline), turn to effect in adjusted normal. when may of change salicylates daily salts thyroid changing guanethidine the of hormones pentamidine risk result insulin metabolic dose hours. thereafter. sulphonamide with type a not body lantus insulin alcohol example, the atypical individually. a regimen your during the high insulin insulin the may or products resulting of inhibitors. use the may to that which may as diazoxide, the slowly when is medicinal phenothiazine nocturnal increase subcutaneously. of under we of or (e.g. to or because in hormones, a diuretics, regimen beta-blockers, should antidiabetic on this progestogens, weeks and of blood. blood sympathomimetic of lantus, that agent insulin if hypo-or oral hypoglycaemia, with sensitivity pentoxifylline, partially, your require insulin diabetes), epinephrine have adjustment experience improved weaken you weight or during a 24 may regimen doses or other to become an of this changing be sympatholytic using include quick dosage treatment insulin as period lantus daily isoniazid, adjustment and reduce sugar potentiate monitoring transition the have or patients type the or fluoxetine, dose may analogues its are regular of mao diabetes substances from can metabolic (sugar disopyramide, insulin, by glargine)category: that response (insulin by to energy. substances intravenously. to of and as first is may is insulin is

Insulin Glargine without prescription